Pcn247 - Treatment Patterns in Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M Scchn) Post Platinum-Based Therapy (Ppbt) in the Immuno-Oncology (Io) Era

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.329
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn264 - Assessment of Treatments and Health Care Utilisation (Hcu) in Spain Following Initial Platinum Therapy for Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn268 - Treatments and Health Care Utilisation (Hcu) in Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Following Initial Platinum Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution

International Journal of Practical Otolaryngology
2019English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Current Recommendations for Systemic Therapy of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Real-World Treatment Patterns, Cost of Care and Effectiveness of Therapies for Patients With Squamous Cell Carcinoma of Head and Neck Pre and Post Approval of Immuno-Oncology Agents

Journal of Medical Economics
Health Policy
2019English

Biomarkers Predict P53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy